Resten-NG: Began Phase I testing

AVI BioPharma Inc. (AVII), Portland, Ore. Product: Resten-NG Business: Cardiovascular Therapeutic category: Antisense Target: C-myc Description: Phosphorodiamidate morpholino antisense compound again...